§ Federal grant opportunity · HT942526AZRPTRRA
DoW Alzheimer’s Transforming Research Award
JoAnn Martin Grantor is accepting applications for DoW Alzheimer’s Transforming Research Award. The deadline is September 24, 2026 and the published award range is Award amount not published.
Key facts
- Funder
- JoAnn Martin Grantor
- Application deadline
- September 24, 2026
- Award range
- Award amount not published
- Eligibility
- Eligibility criteria are published in the funding opportunity announcement.
- Geography
- United States
- Focus areas
- Research
- Opportunity number
- HT942526AZRPTRRA
Program overview
Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Research Award (TrRA) supports non-incremental, robust, well-designed research that drives transformative advancements in reducing risk and preventing the development of Alzheimer’s disease and/or Alzheimer's disease related dementias (AD/ADRD). Distinctive Features: • Applications must address at least one of the following focus areas: ○ Risk Factor Knowledge: Research that advances understanding, identification, and/or validation of risk and/or protective factors, with research outcomes/products focused on accelerating solutions. Projects may include, but are not limited to, research on environmental, epigenetic, genetic, lifestyle, occupational, or other risks not listed here. ○ Risk Reduction Solutions: Research that describes methods, technologies, and strategies that contribute to reducing risk and preventing AD/ADRD. • Clinical research is allowed, however clinical trials and animal research are prohibited. • Preliminary data are required. • Community collaboration is required for research prospectively enrolling human subjects. • Career Initiation or Transition (CIT) Partnership Option: The TrRA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from JoAnn Martin Grantor.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before September 24, 2026, allowing time for registration and validation.
Related grant opportunities
- DoW Alzheimer’s Transforming Diagnosis Award
- Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)
- FY26 Bureau of Land Management Invasive and Noxious Plant Management - Bureau wide
- National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32)
- Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.